Treatment of M.Graves With Radioactive Iodine: Follow-up Study
NCT00525122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2008-05-22
Summary
Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism?
What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?
Conditions
- Hyperthyroidism
Sponsors & Collaborators
-
Medisch Centrum Rijnmond-Zuid, Netherlands
lead OTHER_GOV
Principal Investigators
-
A. Berghout, MD, PhD · Medisch Centrum Rijnmond-Zuid, Netherlands
-
C. van Noord, MD · Medisch Centrum Rijnmond-Zuid, Netherlands
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
NCT05142904 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Radioactive Iodine on the Immune System in Thyroid Cancer
NCT05989555 ·Status: NOT_YET_RECRUITING
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Different I-131 Doses in Graves' Disease
NCT02114619 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China
NCT07040306 ·Status: RECRUITING
-
Observation in the Treatment of Graves' Disease
NCT05043233 ·Status: UNKNOWN
-
Iodine Supplementation in Graves' Hyperthyroidism
NCT06540469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Three-Year Follow-up of Radioiodine Therapy for Goitre
NCT00509483 ·Status: COMPLETED ·Phase: NA
-
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
NCT00970359 ·Status: COMPLETED ·Phase: NA
-
Hyperthyroidism: Methimazole Plus L-carnitine and Selenium
NCT04946123 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
NCT01560299 ·Status: COMPLETED ·Phase: NA
-
Post-Radioiodine Graves' Management: The PRAGMA-Study
NCT01885533 ·Status: COMPLETED
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
NCT04137185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Study of Hyperthyroidism in Children
NCT06570967 ·Status: RECRUITING
-
Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?
NCT00151723 ·Status: UNKNOWN ·Phase: NA
-
Graves' Disease Remission Study: MycoMeth Combo
NCT06068179 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
NCT04971473 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Optimization With a Gamma Camera of the Individualized Patient Dosimetry in Radioiodine Therapy of Thyroid Diseases
NCT06371339 ·Status: COMPLETED ·Phase: NA